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Abstract
Introduction: Recognition of patterns of organ failure may be useful in characterizing the clinical course of
critically ill patients. We investigated the patterns of early changes in organ dysfunction/failure in intensive care
unit (ICU) patients and their relation to outcome.
Methods: Using the database from a large prospective European study, we studied 2,933 patients who had stayed
more than 48 hours in the ICU and described patterns of organ failure and their relation to outcome. Patients were
divided into three groups: patients without sepsis, patients in whom sepsis was diagnosed within the first 48 hours
after ICU admission, and patients in whom sepsis developed more than 48 hours after admission. Organ
dysfunction was assessed by using the sequential organ failure assessment (SOFA) score.
Results: A total of 2,110 patients (72% of the study population) had organ failure at some point during their ICU
stay. Patients who exhibited an improvement in organ function in the first 24 hours after admission to the ICU had
lower ICU and hospital mortality rates compared with those who had unchanged or increased SOFA scores (12.4
and 18.4% versus 19.6 and 24.5%, P < 0.05, pairwise). As expected, organ failure was more common in sepsis than
in nonsepsis patients. In patients with single-organ failure, in-hospital mortality was greater in sepsis than in
nonsepsis patients. However, in patients with multiorgan failure, mortality rates were similar regardless of the
presence of sepsis. Irrespective of the presence of sepsis, delta SOFA scores over the first 4 days in the ICU were
higher in nonsurvivors than in survivors and decreased significantly over time in survivors.
Conclusions: Early changes in organ function are strongly related to outcome. In patients with single-organ failure,
in-hospital mortality was higher in sepsis than in nonsepsis patients. However, in multiorgan failure, mortality rates
were not influenced by the presence of sepsis.
Introduction
Multiple organ failure (MOF) is an evolving clinical syn-
drome triggered by various stimuli and may be a conse-
quence of tissue hypoperfusion with cellular hypoxia,
metabolic dysfunction, and impaired bioenergetic pro-
cesses [1]. MOF is the main cause of morbidity and
mortality in patients admitted to the intensive care unit
(ICU) and is recognized as the final common pathway
preceding death in critically ill patients [2-4]. Sepsis, a
major public health problem, often progresses to MOF
[2,3], which is believed to increase markedly the risk of
death in ICU patients [2,3,5].
A need exists to evaluate organ function better over
time in ICU patients. The Sequential Organ Failure
Assessment (SOFA) score [6-8] was developed as a tool
to describe quantitatively the time course of organ dys-
function [9,10]. Changes in SOFA score have been cor-
related with prognosis (delta SOFA and SOFA max)
[8,10] and are now widely used to assess the effects of
therapeutic interventions [11,12]. The aim of our study
was to investigate the relation between the patterns of
early changes in organ function in the ICU and outcome
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from critical illness. The study set up the hypothesis
that recognition of early changes in organ function may
characterize the clinical course of critically ill patients.
Moreover, we explored the relative roles of sepsis and
MOF in determining outcome in critically ill patients.
Materials and methods
This study is a subanalysis of the prospective, multicen-
ter, observational study, the sepsis occurrence in acutely
ill patients (SOAP) study, which was designed to create
a database of ICU patients in European countries.
Recruitment, data collection, and management are
detailed elsewhere [2]; in brief, all patients older than 15
years admitted to the 198 participating centers (see the
Acknowledgements for a list of participating countries
and centers) between May 1 and May 15, 2002, were
included. Patients who stayed in the ICU for less than
24 hours for routine postoperative observation were not
included. Patients were followed up until death, hospital
discharge, or for 60 days. Because the observational
SOAP study did not require any deviation from routine
medical practice, institutional review board approval was
either waived or expedited in participating institutions,
and informed consent was not required. As such, no
supplementary review-board documents were needed for
the current substudy.
Data were collected prospectively by using preprinted
case-report forms. Data collection on admission
included demographic data and comorbidities. Clinical
and laboratory data for the simplified acute physiology
score (SAPS) II [13] were reported as the worst value
within 24 hours after admission. Microbiologic and clin-
ical infections were reported daily, as well as the antibio-
tics administered. Organ function was evaluated on
admission and daily thereafter, by using the SOFA score
[6]. Data were encoded centrally in the organizing cen-
ter by medical personnel (Department of Intensive Care,
Erasme Hospital), and a number of quality control mea-
sures were carried out to assure consistency of the data
and the quality of data entry [2]. All variables were
defined a priori, and definitions were available on an
Internet-based website throughout the study period.
Definitions
Sepsis syndromes were defined according to consensus
conference definitions [14]. Organ failure was defined as
a SOFA score >2 for any of the six organs/systems eval-
uated, and MOF, as more than one failing organ [7]. An
increase in the SOFA score of at least 1 point was con-
sidered as deterioration in organ function. SOFAmax
was defined as the maximum SOFA score recorded dur-
ing the ICU stay, and SOFAmean, as the mean value
during the ICU stay. Individual organ failures during the
ICU stay were defined according to the SOFAmax for
the corresponding organ. Combinations of organ failures
were considered independent of the time of onset of
each organ failure. The delta SOFA (ΔSOFA) was calcu-
lated as the difference between the SOFA score on a
specific day and the score on the day of admission to
the ICU [8].
Statistical analysis
For the purposes of this analysis, we excluded all
patients who spent less than 48 hours in the ICU. To
investigate the impact of sepsis on organ failure, patients
were divided into three groups; Patients without sepsis,
those in whom sepsis developed within 48 hours after
ICU admission, and those in whom sepsis developed
more than 48 hours after admission to the ICU.
Data were analyzed by using SPSS 13.0 for Windows
(SPSS Inc., Chicago, IL, USA). Descriptive statistics were
computed for all study variables. The Kolmogorov-Smir-
nov test was used to verify the normality of distribution
of continuous variables. Nonparametric tests of compar-
ison were used for variables evaluated as not normally
distributed. Difference testing between groups was per-
formed by using the two-tailed t test, Mann-Whitney U
test, c2 test, and Fisher Exact test, as appropriate, with a
Bonferroni correction for multiple comparisons. Differ-
ences in SOFA scores between groups over time were
assessed by using multifactorial analysis of variance
(ANOVA).
Continuous data are presented as mean ± SD, and
categoric data, as number (%), unless otherwise indi-
cated. All statistics were two-tailed, and a P < 0.05 was
considered to be statistically significant.
Results
Characteristics of the study group
Of the 3,147 patients included in the SOAP database,
2,933 patients stayed in the ICU for more than 48 hours
(Table 1). The admission SOFA score for these patients
was 5.0 ± 3.7; the maximum SOFA, 6.6 ± 4.4; and the
mean SOFA, 5.0 ± 3.7. The median ICU length of stay
was 3.4 (IQ, 2.0 to 7.6) days, and the median length of
hospital stay, 16 (8 to 33) days. The overall ICU and hos-
pital mortality rates were 16.6% and 21.9%, respectively.
Patterns of organ failure and their relation to outcome
On admission to the ICU, 1,675 (57.1%) patients had at
least one organ failure; these patients had ICU and hos-
pital mortality rates of 27.6% and 34.2%, respectively. In
total, 435 (15%) patients developed organ failure in the
ICU. The organ failures most commonly present on the
day of admission to the ICU were of the cardiovascular
(24%) and respiratory (22%) systems, whereas respiratory
(43%) and renal (36%) organ failures were the most
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prevalent during the ICU stay (Table 2). The combina-
tion of respiratory and cardiovascular organ failures was
the most common on admission (9%) and during the
ICU stay (25%).
Hospital mortality rates increased according to the
severity of organ dysfunction/failure as assessed by the
SOFA score (Figure 1) and according to the number of
failing organs (Table 2). The highest hospital mortality
rates were observed in patients with failure of the hepa-
tic or coagulation systems, and in patients with com-
bined coagulation and hepatic or coagulation and
central nervous system (CNS) failure, mortality rates
reached 70% to 80%.
Early changes in organ failure and outcome
The time to achieve SOFAmax was longer in nonsurvi-
vors than in survivors (2 (2 to 3) versus 1 (1 to 2) days;
P < 0.001). Patients who exhibited an improvement or
no change in organ function over the first 24 hours
after admission to the ICU had lower ICU and hospital
mortality rates compared with those whose scores
increased (12.4 and 18.4% versus 19.6 and 24.5%; P <
0.05 pairwise). Likewise, patients who exhibited an
improvement or no change in organ function over the
second day in the ICU had lower ICU and hospital mor-
tality rates compared with those whose scores increased
(13.8 and 20.7% versus 18.6 and 24.1%; P < 0.05 pair-
wise). Delta SOFA scores were higher and remained
higher in nonsurvivors than in survivors over the first 4
days in the ICU; they decreased significantly over time
in survivors (Figure 2).
Impact of sepsis on incidence and outcome from
organ failure
In total, 1,144 (39%) patients had sepsis at some point
during the ICU stay, including 865 during the first 48
hours in the ICU and 279 after 48 hours. MOF occurred
more frequently in patients with sepsis, irrespective of
the time of onset (Table 3). During the ICU stay, renal
failure was the most common organ failure in patients
who never had sepsis, and respiratory failure was the
most common in patients with sepsis.
ICU (24 and 28 versus 11%; P < 0.001 each) and hos-
pital mortality rates (33 and 33 versus 14%; P < 0.001
each) were more than double in patients who had sepsis
within or after 48 hours than in those who never had
sepsis. Mortality from any type of organ failure was
higher in patients with sepsis than in those who did not
have sepsis, irrespective of the time of onset (Table 4).
Hospital mortality rates in patients with single-organ
failure during the ICU stay were higher in patients with
sepsis than in those who never had sepsis (sepsis within
48 hours and sepsis after 48 hours versus no sepsis: hos-
pital mortality, 16 and 13 versus 9%, respectively; P <
0.01 pairwise). However, patients with MOF had similar
mortality rates regardless of whether they had sepsis
(ICU mortality ranging from 23% to 76%, and hospital
mortality ranging from 32% to 89%).
Delta SOFA scores over the first 4 days in the ICU
were higher in nonsurvivors than in survivors, regardless
of the presence of sepsis (Figure 2). SOFA scores
remained elevated in survivors but decreased over time
in survivors, irrespective of the presence of sepsis.
Discussion
The main findings of our study were that (a) whatever
the degree of organ failure at ICU admission, patients
who exhibited an improvement or no change in organ
function during the first 24 to 48 hours in the ICU had
lower mortality rates than did those in whom organ
function worsened; (b) in patients with single-organ fail-
ure during the ICU stay, hospital mortality was signifi-
cantly greater in patients with sepsis than in those
without; (c) patients with MOF had similar mortality
rates, regardless of the presence of sepsis.
Table 1 Characteristics of the patients on ICU admission,
lengths of ICU and hospital stays, and outcomes
Number of patients 2,933
Age, years, median (IQ)a 64 (50-74)
Sex, male/female, % 61.5/38.5





ICU admission source, n (%)b
ER/ambulance 818 (27.9)
Hospital floor 726 (24.8)
OR/recovery room 765 (26.1)




Heart failure 287 (9.8)
Diabetes 208 (7.1)
Cirrhosis 115 (3.9)
Hematologic cancer 63 (2.1)
HIV/AIDS 8 (0.3)
SAPS II score, mean ± SD 35.9 ± 16.4
SOFA score, mean ± SD 5.0 ± 3.7
Duration of ICU stay, days, median (IQ) 3.4 (2.0-7.6)
Duration of hospital stay, days, median (IQ) 16.0 (8.0-33.0)
ICU mortality, n (%)c 486 (16.6)
Hospital mortality, n (%)d 642 (21.9)
aSeven missing values; b292 missing values; cone missing value; d44 missing
values.
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The association between early improvement in organ
function and favorable prognosis has been reported in sev-
eral other studies [8,15,16]. In 287 patients with severe
sepsis, Russell et al. [15] reported that worsening of organ
function over the first 3 days after the onset of sepsis syn-
drome was associated with higher 30-day mortality rates
than was improvement or no change in organ function. In
a study of 1,036 patients with severe sepsis, Levy et al. [16]
also reported that early changes (baseline to day 1) in
organ function were closely related to outcome. Interest-
ingly, we found that the evolution of organ function on
the second day in the ICU was associated with outcome,
irrespective of the degree of organ function on admission
to the ICU. These observations may help to identify
patients in whom continuing therapy is likely to be futile
[17], or to define patients who may benefit from a change
in therapeutic strategy (for example, another surgical
intervention, a change in antibiotic therapy, or more-
intensive vasoactive support).
We found that the time required to achieve the high-
est degree of organ dysfunction/failure was shorter in
survivors than in non-survivors. However, no specific
pattern of organ failure was related to the presence of
sepsis in our patients. Dulhunty et al. [18] reported that
CNS dysfunction was more commonly present in
patients with systemic inflammatory response syndrome
(SIRS) but no infection and was associated more com-
monly with death in these patients than in those with
sepsis. However, the assessment of neurologic failure
using the GCS may be confounded by the frequent use
of sedative agents in critically ill patients.
Several studies [3,6,16,19] have investigated the epide-
miology and outcome of sepsis-associated organ dys-
function/failure; however, studies in the nonsepsis
population are scarce [4,18]. Dulhunty et al. [18] investi-
gated the time course of organ dysfunction and outcome
in patients with severe sepsis and patients with severe
noninfectious SIRS, but excluded all other patients,
Table 2 ICU and hospital mortality rates according to the number, type, and combinations of failed organs
On admission to the ICU At any time during ICU stay
Incidence (%) Mortality (%) Incidence (%) Mortality (%)
ICU Hospital ICU Hospital
Number of failed organs
1 927 (32) 17 23 942 (32) 5 11
2 524 (18) 28 37 677 (23) 24 33
3 181 (6) 45 50 334 (11) 44 51
>3 43 (1) 58 70 157 (5) 73 79
Type of organ failurea
Cardiovascular 717 (24) 31 39 993 (34) 35 41
Respiratory 653 (22) 27 33 1,258 (43) 29 36
CNS 601 (21) 32 39 757 (26) 38 45
Renal 513 (18) 26 35 1,058 (36) 28 36
Coagulation 130 (18) 36 45 290 (10) 44 54
Hepatic 82 (3) 33 40 165 (6) 38 45
Combinations of two organ failures
Respiratory + cardiovascular 274 (9) 39 46 726 (25) 39 46
Respiratory + renal 120 (4) 42 49 543 (19) 41 48
Respiratory + CNS 197 (7) 38 47 488 (17) 43 50
Hepatic + renal 24 (1) 38 46 98 (3) 47 51
Respiratory + hepatic 22 (1) 50 50 109 (4) 47 53
Renal + cardiovascular 24 (1) 38 46 481 (16) 47 55
CNS + cardiovascular 220 (8) 39 48 390 (13) 50 55
CNS + renal 109 (4) 39 51 308 (11) 49 57
Hepatic + cardiovascular 29 (1) 48 52 97 (3) 55 59
Respiratory + coagulation 34 (1) 47 53 203 (7) 53 63
Coagulation + cardiovascular 51 (2) 47 59 201 (7) 56 65
Coagulation + renal 25 (1) 52 68 159 (5) 59 67
Coagulation + hepatic 15 (1) 67 80 64 (2) 63 70
Hepatic + CNS 29 (1) 58 67 97 (3) 66 71
Coagulation + CNS 23 (1) 65 74 113 (4) 69 79
aAlone or in combination with other organs.
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which may explain the higher ICU mortality rate of 25%
in their noninfected population, compared with the 20%
in our study. In our study, hospital mortality from sin-
gle-organ failure during the ICU stay was greater in
patients with sepsis than in those who never had sepsis;
interestingly, mortality rates from MOF were similar,
regardless of the presence of sepsis. In their large cohort
of ICU patients in Australasia, Dulhunty et al. [18]
reported similar findings.
Interestingly, the highest hospital mortality rates were
observed in patients with failure of the hepatic or coagu-
lation systems. Because disturbances of coagulation
parameters are closely related with liver failure, this
study highlights the enormous importance of liver func-
tion on the outcome of ICU patients. Umegaki et al.
[20] also recently reported that hepatic dysfunction
compared with other organ dysfunction was associated
with the highest mortality rates in a study including
4,196 patients with severe sepsis.
A key strength of our study is the large database of
patients and its multicenter, pan-European nature. The
SOAP study was performed several years ago, but
organ-dysfunction patterns are likely to change slowly
over time, so these data are still relevant. Nevertheless,
our study has some limitations. First, participation was
on a voluntary basis. Second, our results can be extrapo-
lated only to ICUs with a similar case-mix. Third, other
factors, which were not considered in our report, may
influence the outcome of MOF, including comorbidities,
severity of illness, and local practice. We also did not
discriminate between acute and chronic organ failure in
our analysis.
Conclusions
Although sepsis patients have worse outcomes than do
nonsepsis patients, the differences are primarily in
patients with only one organ failure, as the mortality in
MOF is very high, regardless of the presence of sepsis.
In all patients (with or without sepsis), changes in organ
function during the first 24 to 48 hours after ICU
admission can determine outcome, irrespective of the
baseline degree of organ dysfunction. These patterns of
organ failure and their relation to outcome may be use-
ful in prognostication and, hence, in risk stratification of
critically ill patients, including in the setting of clinical
trials.
Key messages
• Whatever the degree of organ failure on admission to
the ICU, patients who exhibited an improvement in
organ function during the first 24 to 48 hours in the
ICU had lower mortality rates than did the other
patients.
• Higher mortality rates in sepsis compared with non-
sepsis patients are primarily the result of higher mortal-
























SOFA score: ႑ on admission ႑ max
Figure 1 Hospital mortality rates according to SOFA score on admission (gray columns) and the maximum SOFA score (black
columns).
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Figure 2 Error bars representing the delta SOFA scores (mean ± 95% CI) during the first 4 days in the ICU in survivors (solid circles)
and nonsurvivors (solid triangles) in the whole cohort (A) (n = 2,933) and in patients without (n = 1,789) (B), or with sepsis (n =
1,144) (C). *P < 0.05 compared with ΔSOFA 24-0 (ANOVA with Bonferroni correction for multiple comparisons); †multifactorial ANOVA; P < 0.05
compared with survivors.
Table 3 Incidence of organ failure according to the presence of sepsis
No sepsis (n = 1,789) Sepsis within 48 hours (n = 865) Sepsis after 48 hours (n = 279)
Organ failure on admission to the ICU
Number of failing organs, median (IQ) 0 (0-1) 1 (0-2)a 1 (0-2)a
Any organ failure, n (%) 874 (49) 607 (70)a 194 (70)a
1 563 (32) 271 (31) 93 (33)
2 228 (13) 219 (25)a 77 (28)a
3 72 (4) 87 (10)a 22 (8)a
>3 11 (1) 30 (3)b 2 (1)
Type of organ failure
Respiratory 320 (18) 256 (30)a 77 (28)a
CNS 317 (18) 199 (23)a 85 (31)a
Cardiovascular 306 (17) 320 (37)a 91 (33)a
Renal 258 (14) 210 (24)a 45 (16)
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Table 3 Incidence of organ failure according to the presence of sepsis (Continued)
Coagulation 49 (3) 69 (8)a 12 (4)
Hepatic 30 (2) 41 (5)a 11 (4)b
Organ failure at any time during ICU stay
Number of failing organs, median (IQ) 1 (0-2) 2 (1-3) 2 (1-3)
Any organ failure, n (%) 1,120 (63) 732 (85)a 258 (92)a
1 652 (36) 230 (27)a 60 (22)a
2 307 (17) 253 (29)a 117 (42)a
3 121 (7) 158 (18)a 55 (20)a
>3 40 (2) 98 (11)a 26 (9)a
Type of organ failure
Renal 559 (31) 386 (45)a 113 (41)a
Respiratory 514 (29) 528 (61)a 216 (77)a
Cardiovascular 406 (23) 432 (50)a 155 (56)a
CNS 368 (21) 270 (31)a 119 (43)a
Coagulation 102 (6) 143 (17)a 45 (16)a
Hepatic 49 (3) 84 (10)a 32 (12)a
CNS, central nervous system; IQ, interquartile range. bP < 0.05; aP < 0.01 compared with patients without sepsis (pairwise comparisons with Bonferroni correction
for multiple comparisons).
Table 4 ICU and hospital mortality rates according to the number and type of failed organs and the presence of
sepsis




hours n = 865
Sepsis after 48




hours n = 865
Sepsis after 48
hours n = 279
On admission to the ICU
Any organ failure 20 30a 30a 25 40a 37a
1 13 20a 30a 18 30a 36a
2 25 30 29 33 41a 38a
3 44 48 32 47 56 36
> 3 55 60 50 64 73 50
Type of organ
failure
Respiratory 10 34a 31a 25 44a 36a
CNS 34 32 27a 38 42b 36a
Cardiovascular 25 38a 28b 31 48a 33a
Renal 20 32a 31a 26 44a 42a
Coagulation 22 46a 33b 27 58a 50b
Hepatic 20 34a 64a 28 42a 64a
At any time during the ICU stay
Any organ failure 17 28a 30a 22 38a 37a
1 5 6 7 9 16a 13a
2 24 23 27 32 34 34
3 47 43 42 50 52 51
>3 76 71 69 76 89 77
Type of organ
failure
Renal 20 38a 41a 26 50a 50a
Respiratory 24 32a 32a 28 41a 40a
Cardiovascular 29 40a 37a 33 49a 42a
CNS 36 40a 39a 40 50a 46a
Coagulation 33 49a 53a 41 60a 64a
Hepatic 27 42a 47a 33 49a 50a
CNS, central nervous system; IQ, interquartile range. bP < 0.05; aP < 0.01 compared with patients without sepsis (pairwise comparisons with Bonferroni correction
for multiple comparisons).
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• Mortality rates in patients with multiorgan failure
are high, irrespective of the presence of sepsis.
• Improved knowledge of patterns of organ failure and
their relation to outcome may be useful in prognostica-
tion and, hence, in risk stratification of critically ill
patients.
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Hospital Clinic of Barcelona (E. Zavala); Sweden: Central Hospital of
Kristianstad (K. Brodersen); Stockholm Soder Hospital (J. Haggqvist); Sunderby
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